101 related articles for article (PubMed ID: 7530197)
1. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders.
Watanabe D; Suda T; Hashimoto H; Nagata S
EMBO J; 1995 Jan; 14(1):12-8. PubMed ID: 7530197
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.
Shimizu M; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
Cancer Immunol Immunother; 1998 Nov; 47(3):143-8. PubMed ID: 9829839
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived Fas ligand induces toxicity in lymphoid organs and plays an important role in successful chemotherapy.
Nagarkatti N
Cancer Immunol Immunother; 2000 Apr; 49(1):46-55. PubMed ID: 10782865
[TBL] [Abstract][Full Text] [Related]
4. Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically.
Mohamood AS; Guler ML; Xiao Z; Zheng D; Hess A; Wang Y; Yagita H; Schneck JP; Hamad AR
Am J Pathol; 2007 Jul; 171(1):97-106. PubMed ID: 17591957
[TBL] [Abstract][Full Text] [Related]
5. The role of intrahepatic CD3+/CD4-/CD8- double negative T (DN T) cells in enhanced acetaminophen toxicity.
Getachew Y; Cusimano FA; James LP; Thiele DL
Toxicol Appl Pharmacol; 2014 Oct; 280(2):264-71. PubMed ID: 25168425
[TBL] [Abstract][Full Text] [Related]
6. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis.
Kuwano K; Hagimoto N; Kawasaki M; Yatomi T; Nakamura N; Nagata S; Suda T; Kunitake R; Maeyama T; Miyazaki H; Hara N
J Clin Invest; 1999 Jul; 104(1):13-9. PubMed ID: 10393694
[TBL] [Abstract][Full Text] [Related]
7. FasL is a catabolic factor in alveolar bone homeostasis.
Apaza Alccayhuaman KA; Heimel P; Lee JS; Tangl S; Kuchler U; Marchesan J; Panahipour L; Lettner S; Matalová E; Gruber R
J Clin Periodontol; 2023 Mar; 50(3):396-405. PubMed ID: 36384160
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune lymphoproliferative syndrome caused by a homozygous FasL mutation that disrupts FasL assembly.
Sobh A; Crestani E; Cangemi B; Kane J; Chou J; Pai SY; Notarangelo LD; Al-Herz W; Geha RS; Massaad MJ
J Allergy Clin Immunol; 2016 Jan; 137(1):324-327.e2. PubMed ID: 26456038
[No Abstract] [Full Text] [Related]
9. FasL impacts Tgfb signaling in osteoblastic cells.
Kratochvilova A; Knopfova L; Gregorkova J; Gruber R; Janeckova E; Chai Y; Matalova E
Cells Dev; 2024 May; ():203929. PubMed ID: 38810946
[TBL] [Abstract][Full Text] [Related]
10. The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis.
Alvarez-Diaz S; Dillon CP; Lalaoui N; Tanzer MC; Rodriguez DA; Lin A; Lebois M; Hakem R; Josefsson EC; O'Reilly LA; Silke J; Alexander WS; Green DR; Strasser A
Immunity; 2016 Sep; 45(3):513-526. PubMed ID: 27523270
[TBL] [Abstract][Full Text] [Related]
11. Lymphocytic profiling in thyroid cancer provides clues for failure of tumor immunity.
Imam S; Paparodis R; Sharma D; Jaume JC
Endocr Relat Cancer; 2014 Jun; 21(3):505-16. PubMed ID: 24623740
[TBL] [Abstract][Full Text] [Related]
12. FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells.
Juvet SC; Thomson CW; Kim EY; Han M; Zhang L
PLoS One; 2013; 8(6):e65253. PubMed ID: 23762329
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic mechanisms employed by mouse T cells to destroy pancreatic β-cells.
Varanasi V; Avanesyan L; Schumann DM; Chervonsky AV
Diabetes; 2012 Nov; 61(11):2862-70. PubMed ID: 22773667
[TBL] [Abstract][Full Text] [Related]
14. Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions.
Juvet SC; Zhang L
J Mol Cell Biol; 2012 Feb; 4(1):48-58. PubMed ID: 22294241
[TBL] [Abstract][Full Text] [Related]
15. Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.
Magerus-Chatinet A; Neven B; Stolzenberg MC; Daussy C; Arkwright PD; Lanzarotti N; Schaffner C; Cluet-Dennetiere S; Haerynck F; Michel G; Bole-Feysot C; Zarhrate M; Radford-Weiss I; Romana SP; Picard C; Fischer A; Rieux-Laucat F
J Clin Invest; 2011 Jan; 121(1):106-12. PubMed ID: 21183795
[TBL] [Abstract][Full Text] [Related]
16. Enhanced contact allergen- and UVB-induced keratinocyte apoptosis in the absence of CD95/Fas/Apo-1.
Hedrych-Ozimina A; Behrendt K; Hao Z; Pofahl R; Ussath D; Knaup R; Krieg T; Haase I
Cell Death Differ; 2011 Jan; 18(1):155-63. PubMed ID: 20689557
[TBL] [Abstract][Full Text] [Related]
17. Programmed cell death of dendritic cells in immune regulation.
Chen M; Wang J
Immunol Rev; 2010 Jul; 236():11-27. PubMed ID: 20636805
[TBL] [Abstract][Full Text] [Related]
18. Fas activation increases neural progenitor cell survival.
Knight JC; Scharf EL; Mao-Draayer Y
J Neurosci Res; 2010 Mar; 88(4):746-57. PubMed ID: 19830835
[TBL] [Abstract][Full Text] [Related]
19. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
O' Reilly LA; Tai L; Lee L; Kruse EA; Grabow S; Fairlie WD; Haynes NM; Tarlinton DM; Zhang JG; Belz GT; Smyth MJ; Bouillet P; Robb L; Strasser A
Nature; 2009 Oct; 461(7264):659-63. PubMed ID: 19794494
[TBL] [Abstract][Full Text] [Related]
20. The many roles of FAS receptor signaling in the immune system.
Strasser A; Jost PJ; Nagata S
Immunity; 2009 Feb; 30(2):180-92. PubMed ID: 19239902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
